Cargando…

ACE2, Metformin, and COVID-19

COVID-19 is becoming a leading cause of mortality throughout the world, and few effective therapies are currently available. Angiotensin converting enzyme 2 (ACE2) is essential to COVID-19 pathogenesis, as the binding of SARS-CoV-2 spike protein (S protein) is required for viral entry and developmen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malhotra, Atul, Hepokoski, Mark, McCowen, Karen C., Y-J Shyy, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452173/ https://www.ncbi.nlm.nih.gov/pubmed/32818905 http://dx.doi.org/10.1016/j.isci.2020.101425

Ejemplares similares

Inpatient Use of Metformin and Acarbose Is Associated with Reduced Mortality of COVID-19 Patients with Type 2 Diabetes Mellitus
por: Li, Willis, et al.
Publicado: (2021)

Inpatient use of metformin and acarbose is associated with reduced mortality of COVID‐19 patients with type 2 diabetes mellitus
por: Li, Jinghong, et al.
Publicado: (2021)

Metformin Use in Diabetes Prior to Hospitalization: Effects on Mortality in Covid-19
por: Li, Jinghong, et al.
Publicado: (2020)

Sleep Apnea, Obesity, and Diabetes — an Intertwined Trio
por: Kurnool, Soumya, et al.
Publicado: (2023)

Abstract #1176119: Development of New Onset, Protracted Hyperglycemia Triggered by COVID-19 Vaccination with Ultimate Resolution in an Individual without Prior Dysglycemia
por: Gerwer, Johanna, et al.
Publicado: (2022)

Bilious Typhus Relapsing Fever
por: McCowen, W. T.
Publicado: (1906)

SAT557 Unexpected Whole Body Scan Finding
por: Gastelum, Alheli Arce, et al.
Publicado: (2023)

FRI233 Adrenal Insufficiency Due To An Unusual Culprit
por: Decamps, Scarlett, et al.
Publicado: (2023)

SAT339 Osteopenia In The Setting of Mild Autonomous Cortisol Secretion
por: Mao, Jimmy J, et al.
Publicado: (2023)

ACE and ACE2: insights from Drosophila and implications for COVID-19
por: Herrera, Paul, et al.
Publicado: (2021)

MON-115 Inappropriate Ordering of Parathyroid Scintigraphy in an Academic Medical Center
por: Kimura, Brad, et al.
Publicado: (2020)

Alpelisib-Induced Hyperglycemia- A Small Case Series
por: Ekanayake, Preethika Subashini, et al.
Publicado: (2021)

What Is the Evidence Globally for Culturally Safe Strategies to Improve Breast Cancer Outcomes for Indigenous Women in High Income Countries? A Systematic Review
por: Christie, Vita, et al.
Publicado: (2021)

Hyperthyroidism Due to Graves Disease After Radiofrequency Ablation
por: McAninch, Elizabeth A, et al.
Publicado: (2023)

ACE2 and COVID-19 and the resulting ARDS
por: Zhang, Xiaoqing, et al.
Publicado: (2020)

Rebound Vertebral Fractures in a Patient With Lung Cancer After Oncology-Dose Denosumab Discontinuation: A Cautionary Tale
por: Tyan, Alexander, et al.
Publicado: (2019)

COVID-19 susceptibility: potential of ACE2 polymorphisms
por: Chaudhary, Mayank
Publicado: (2020)

ACE2, Circumventricular Organs and the Hypothalamus, and COVID-19
por: Ong, Wei-Yi, et al.
Publicado: (2022)

Retrosynthetic strategies and their impact on synthesis of arcutane natural products
por: McCowen, Shelby V., et al.
Publicado: (2020)

Leukocytosis and PTHrP-Mediated Hypercalcemia: Ominous Signs in an Indolent Thyroid Nodule
por: Gerwer, Johanna Elizabeth, et al.
Publicado: (2021)

ACE2 Is an Adjacent Element of Atherosclerosis and COVID-19 Pathogenesis
por: Poznyak, Anastasia V., et al.
Publicado: (2021)

RAAS, ACE2 and COVID-19; a mechanistic review
por: Elshafei, Ahmed, et al.
Publicado: (2021)

Advances in Targeting ACE2 for Developing COVID-19 Therapeutics
por: Suvarnapathaki, Sanika, et al.
Publicado: (2022)

Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19
por: Ni, Wentao, et al.
Publicado: (2020)

ACE2, the Counter-Regulatory Renin–Angiotensin System Axis and COVID-19 Severity
por: Triposkiadis, Filippos, et al.
Publicado: (2021)

Assessment of ACE1 variants and ACE1/ACE2 expression in COVID-19 patients
por: Akbari, Mohammadarian, et al.
Publicado: (2022)

The Yin and Yang of ACE/ACE2 Pathways: The Rationale for the Use of Renin-Angiotensin System Inhibitors in COVID-19 Patients
por: Zamai, Loris
Publicado: (2020)

The Protective Potential Role of ACE2 against COVID-19
por: Golab, Fereshteh, et al.
Publicado: (2023)

ACE2 and COVID-19: using antihypertensive medications and pharmacogenetic considerations
por: Snyder, Eric M, et al.
Publicado: (2020)

Gastrointestinal cancers, ACE-2/TMPRSS2 expression and susceptibility to COVID-19
por: Shafiee, Sepehr, et al.
Publicado: (2021)

COVID-19: The Influence of ACE Genotype and ACE-I and ARBs on the Course of SARS-CoV-2 Infection in Elderly Patients
por: Sieńko, Jerzy, et al.
Publicado: (2020)

Role of ACE, ACE2 and Neprilysin in the Kidney
por: Chappell, Mark C.
Publicado: (2007)

Calcium Signaling Pathway Is Involved in the Shedding of ACE2 Catalytic Ectodomain: New Insights for Clinical and Therapeutic Applications of ACE2 for COVID-19
por: García-Escobar, Artemio, et al.
Publicado: (2022)

Polymorphisms in ACE, ACE2, AGTR1 genes and severity of COVID-19 disease
por: Sabater Molina, Maria, et al.
Publicado: (2022)

The effects of ACE2 expression mediating pharmacotherapy in COVID-19 patients
por: van Kimmenade, R. R. J., et al.
Publicado: (2021)

The Role of ACE, ACE2, and AGTR2 Polymorphisms in COVID-19 Severity and the Presence of COVID-19-Related Retinopathy
por: Jevnikar, Kristina, et al.
Publicado: (2022)

ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19
por: Dong, Mengzhen, et al.
Publicado: (2020)

The Intersection between COVID-19, the Gene Family of ACE2 and Alzheimer’s Disease
por: Haghighi, Mahdi Montazer, et al.
Publicado: (2020)

Variants in ACE2; potential influences on virus infection and COVID-19 severity
por: Bakhshandeh, Behnaz, et al.
Publicado: (2021)

Recent advance of ACE2 and microbiota dysfunction in COVID-19 pathogenesis
por: Yu, Zhidan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3acud5ldd2ai265c77eub9drvo